MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in airtight containers.

Provenance

This compatibility recommendation is derived from Zydol SR 150mg tablets (Grunenthal Ltd).

Stability Notes

No special precautions for storage.

Provenance

Compatiblity recommendation derived from Nortriptyline 10mg tablets (Advanz Pharma).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 25mg tablets (Advanz Pharma Ltd).

Stability Notes

Store in an airtight container, protect from light and moisture.

Provenance

This compatibility recommendation is derived from Ferrous sulfate 200mg tablets (Sandoz Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Procoralan 5mg tablets (Servier Laboratories Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Procoralan 7.5mg tablets (Servier Laboratories Ltd).

Stability Notes

Should be stored in tight, light resistant containers and protected from excessive moisture.

Provenance

This compatibility recommendation is derived from Clarityn Allergy 10mg tablets (Bayer Plc) and Loratadine 10mg tablets (Accord Healthcare Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldomet 250mg tablets (Aspen Pharma Trading Ltd) and Methyldopa 250mg tablets (Sovereign Medical Ltd).

Stability Notes

Store in airtight containers and protect from light.

Provenance

This compatibility recommendation is derived from Thiamine 50mg tablets (Accord Healthcare Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldomet 500mg tablets (Aspen Pharma Trading Ltd) and Methyldopa 500mg tablets (Sovereign Medical Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.